Academic literature on the topic 'Bioavailability'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Bioavailability.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Bioavailability"
Stielow, Marlena, Adrianna Witczyńska, Natalia Kubryń, Łukasz Fijałkowski, Jacek Nowaczyk, and Alicja Nowaczyk. "The Bioavailability of Drugs—The Current State of Knowledge." Molecules 28, no. 24 (December 11, 2023): 8038. http://dx.doi.org/10.3390/molecules28248038.
Full textHOLLMAN, PETER C. H. "Bioavailability." Nutrition Today 35, no. 5 (September 2000): 187–90. http://dx.doi.org/10.1097/00017285-200009000-00006.
Full textANB, Singab. "Bioavailability of Natural Products." Bioequivalence & Bioavailability International Journal 3, no. 1 (January 4, 2019): 1–2. http://dx.doi.org/10.23880/beba-16000137.
Full textThilakarathna, Surangi, and H. Rupasinghe. "Flavonoid Bioavailability and Attempts for Bioavailability Enhancement." Nutrients 5, no. 9 (August 28, 2013): 3367–87. http://dx.doi.org/10.3390/nu5093367.
Full textRick Mullin. "Confronting bioavailability." C&EN Global Enterprise 100, no. 34 (September 26, 2022): 17–21. http://dx.doi.org/10.1021/cen-10034-feature1.
Full textHassan, M., P. Ljungman, P. Bolme, O. Ringden, Z. Syruckova, A. Bekassy, J. Stary, I. Wallin, and N. Kallberg. "Busulfan bioavailability." Blood 84, no. 7 (October 1, 1994): 2144–50. http://dx.doi.org/10.1182/blood.v84.7.2144.2144.
Full textHassan, M., P. Ljungman, P. Bolme, O. Ringden, Z. Syruckova, A. Bekassy, J. Stary, I. Wallin, and N. Kallberg. "Busulfan bioavailability." Blood 84, no. 7 (October 1, 1994): 2144–50. http://dx.doi.org/10.1182/blood.v84.7.2144.bloodjournal8472144.
Full textPeck, Brian. "Calcium Bioavailability." American Journal of Therapeutics 6, no. 6 (November 1999): 323–24. http://dx.doi.org/10.1097/00045391-199911000-00006.
Full textEnglyst, Klaus N., and Hans N. Englyst. "Carbohydrate bioavailability." British Journal of Nutrition 94, no. 1 (July 2005): 1–11. http://dx.doi.org/10.1079/bjn20051457.
Full textMcNulty, Helene, and Kristina Pentieva. "Folate bioavailability." Proceedings of the Nutrition Society 63, no. 4 (November 2004): 529–36. http://dx.doi.org/10.1079/pns2004383.
Full textDissertations / Theses on the topic "Bioavailability"
Fresen, John Lawrence. "Statistical aspects of bioavailability." Master's thesis, University of Cape Town, 1985. http://hdl.handle.net/11427/17004.
Full textIn 1984 it became legal for pharmacists to offer customers a cheaper generic alternative for a given prescription. The motivation for this was the excessively high cost of brand name drugs. The substitution of a generic alternative for a brand name drug is based on the assumption that drugs with a comparable chemical composition will have a similar therapeutic effect. The fact that this supposition is not always true has been demonstrated by a number of particular drugs, digoxon being perhaps the most vivid example. The objective of this thesis is to review the statistical aspects associated with (i) measuring the bioavailability of a drug (Chapter 2) (ii) establishing the equivalence of a new and standard formulation of a drug (Chapter 3). In the process of reviewing the literature two problems were identified. Firstly, it is commonly assumed that bioavailability parameters follow either the normal or lognormal distribution. This assumption is difficult to defend, hence procedures based on such assumptions became suspect. Secondly, bioavailability is inherently multivariate whereas in practice univariate procedures are employed. Efren's bootstrap method, which does not rest on assumptions about the underlying distribution, is proposed as a tool for assessing bioequivalence. A new measure of bioequivalence, the Index of Concordance, is proposed. This index can be computed with equal ease for univariate or multivariate data using the bootstrap (Chapter 5). The bootstrap idea of resampling the data can also be applied to compartmental modelling of bioavailability data. One result of this is a nonparametric estimate of the underlying distribution of the bioavailability parameters (Chapter 6). The bootstrap is, on its own, a fascinating concept. A review of the bootstrap is given in Chapter 4.
Menjoge, A. R. "Enhancing bioavailability of drugs." Thesis(Ph.D.), CSIR-National Chemical Laboratory, Pune, 2006. http://dspace.ncl.res.in:8080/xmlui/handle/20.500.12252/2512.
Full textMontaseri, Hashem. "Taxol, solubility, stability, and bioavailability." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp05/nq21604.pdf.
Full textStroud, Jacqueline L. "Bioavailability of hydrocarbons in soils." Thesis, Lancaster University, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.441365.
Full textJaganath, Indu Bala. "Dietary flavonoids : bioavailability and biosynthesis." Thesis, University of Glasgow, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.418903.
Full textJugdaohsingh, Ravin. "Soluble silica and aluminium bioavailability." Thesis, King's College London (University of London), 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.312026.
Full textRe, Roberta. "Lycopene : antioxidant properties and bioavailability." Thesis, King's College London (University of London), 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.248044.
Full textMuchow, Marc. "Nanocarriers for oral bioavailability enhancement." Thesis, Nancy 1, 2009. http://www.theses.fr/2009NAN10073/document.
Full textThe overall goal of this work consisted in ameliorating the bioavailability of drugs known for their poor hydrosolubility (testosterone) or for their lipidic character (omega-3 fatty acids). This was achieved using lipid nanoparticle systems and nanocrystals In case of testosterone the work consisted of the development of an oral dosage form with superior properties compared to the currently commercially available oral system (Andriol Testocaps®). The other part of this work was the design of a lipid nanoparticle-based omega- 3 fatty acid formulation, which, despite the use of cheap fish oil as source of omega-3 fatty acids, has low smell and taste properties while nevertheless being stable. The development of the oral testosterone drug delivery system was accomplished on the basis of lipid nanoparticles technology and also using drug nanocrystal technology. In both cases, systems could be developed that met the requirements with regards to drug loading (NLC) and stability (NLC and drug nanocrystals). Up to 30 % of testosterone undecanoate could be incorporated into the lipid phase of the NLC. Furthermore, the production of particles with different lipids, which are supposed to promote lymphatic absorption and hence the bioavailability of the hormone. Drug nanocrystals of testosterone (T) and testosterone undecanoate (TU) were prepared with a mean size of about 470 nm (TU) and 860 nm (T). Also with this system, an enhanced lymphatic absorption was expected. The bioavailabilites of the developed NLC based drug delivery systems were all higher than the bioavailability of the product on the market when no additional lipid was supplied. This gives reason to believe, that the influence of co-administered food on the bioavailability of the systems is less pronounced than with Andriol Testocaps®. Based on the findings that lipid nanoparticles can improve oral bioavailability, the development of an omega-3 fatty acids nanoparticulate system (NLC) out of cheap fish oil was a logic step. The oral bioavailability of the omega-3 fatty acids is much higher than the one of TU (about 70 %). Through the use of NLC technology, the taste and smell is even more reduced. It was rather unexpected that we achieved to have a formulation that consisted of 70 % lipid phase (and 30 % water) but still was paste-like and easy to redisperse. This makes the use of the paste as an additive in food and beverages possible to better supply the patient with essential omega-3 fatty acids
Koprivnjak, Jean-François. "Natural Organic Matter: Isolation and Bioavailability." Diss., Georgia Institute of Technology, 2007. http://hdl.handle.net/1853/14564.
Full textKoprivnjak, Jean-Franȯis. "Natural organic matter isolation and bioavailability /." Available online, Georgia Institute of Technology, 2007, 2007. http://etd.gatech.edu/theses/available/etd-04082007-154052/.
Full textPerdue, E. Michael, Committee Chair ; Ingall, Ellery, Committee Member ; Stack, Andrew, Committee Member ; Nenes, Athanasios, Committee Member ; Pfromm, Peter, Committee Member.
Books on the topic "Bioavailability"
Hu, Ming, and Xiaoling Li, eds. Oral Bioavailability. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2011. http://dx.doi.org/10.1002/9781118067598.
Full textEl-Kattan, Ayman F. Oral Bioavailability Assessment. Hoboken, New Jersey: John Wiley & Sons, Inc., 2017. http://dx.doi.org/10.1002/9781118916926.
Full textF, Smolen Victor, and Ball LuAnn, eds. Controlled drug bioavailability. New York: Wiley, 1985.
Find full textde, Waterbeemd Han van, Lennernäs Hans, and Artursson Per, eds. Drug bioavailability: Estimation of solubility, permeability, absorption, and bioavailability. Weinheim: Wiley-VCH, 2003.
Find full textname, No. Drug bioavailability: Estimation of solubility, permeability, absorption and bioavailability. Weinheim: Wiley-VCH, 2003.
Find full textTesta, Bernard, and Han van de Waterbeemd. Drug bioavailability: Estimation of solubility, permeability, absorption and bioavailability. 2nd ed. Weinheim: Wiley-VCH, 2009.
Find full textKies, Constance, ed. Copper Bioavailability and Metabolism. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0537-8.
Full textKies, Constance, ed. Nutritional Bioavailability of Manganese. Washington, DC: American Chemical Society, 1987. http://dx.doi.org/10.1021/bk-1987-0354.
Full textKies, Constance, ed. Nutritional Bioavailability of Calcium. Washington, D.C.: American Chemical Society, 1985. http://dx.doi.org/10.1021/bk-1985-0275.
Full text1934-, Kies Constance, American Chemical Society Meeting, and American Chemical Society. Division of Agricultural and Food Chemistry., eds. Nutritional bioavailability of calcium. Washington, D.C: American Chemical Society, 1985.
Find full textBook chapters on the topic "Bioavailability"
Nahler, Gerhard. "bioavailability." In Dictionary of Pharmaceutical Medicine, 15. Vienna: Springer Vienna, 2009. http://dx.doi.org/10.1007/978-3-211-89836-9_118.
Full textSchwab, Manfred. "Bioavailability." In Encyclopedia of Cancer, 1. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_626-2.
Full textTyrer, Peter J., Mark Slifstein, Joris C. Verster, Kim Fromme, Amee B. Patel, Britta Hahn, Christer Allgulander, et al. "Bioavailability." In Encyclopedia of Psychopharmacology, 227. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_1602.
Full textHill, Keith, Tom Baranowski, Walter Schmidt, Nicole Prommer, Michel Audran, Philippe Connes, Ramiro L. Gutiérrez, et al. "Bioavailability." In Encyclopedia of Exercise Medicine in Health and Disease, 118. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-540-29807-6_2147.
Full textda Costa, Monica Ferreira, Helena do Amaral Kehrig, and Isabel Maria Neto da Silva Moreira. "Bioavailability." In Encyclopedia of Estuaries, 75. Dordrecht: Springer Netherlands, 2015. http://dx.doi.org/10.1007/978-94-017-8801-4_134.
Full textQuiroga, Pablo A. M. "Bioavailability." In The ADME Encyclopedia, 107–16. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-84860-6_129.
Full textQuiroga, Pablo A. M. "Bioavailability." In The ADME Encyclopedia, 1–10. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-51519-5_129-1.
Full textGünther, Klaus. "Bioavailability." In Diet for Iron Deficiency, 77–97. Berlin, Heidelberg: Springer Berlin Heidelberg, 2023. http://dx.doi.org/10.1007/978-3-662-65608-2_7.
Full textHu, Ming, and Xiaoling Li. "Barriers to Oral Bioavailability-An Overview." In Oral Bioavailability, 1–5. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2011. http://dx.doi.org/10.1002/9781118067598.ch1.
Full textTompkins, Leslie M., and Hongbing Wang. "Liver Drug Metabolism." In Oral Bioavailability, 127–44. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2011. http://dx.doi.org/10.1002/9781118067598.ch10.
Full textConference papers on the topic "Bioavailability"
Emanuele, R. M., and J. Fareed. "THE EFFECT OF MOLECULAR WEIGHT ON THE RELATIVE BIOAVAILABILITY OF HEPARIN." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644179.
Full textGough, MS, MM Morgan, CM Mack, DC Darling, LM Frasier, KP Doolin, MJ Apostolakos, et al. "Reduced Arginine Bioavailability in Sepsis." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a1157.
Full textBorel, P. "Nutrigenetic of fat-soluble microconstituents bioavailability." In 13th World Congress of Food Science & Technology. Les Ulis, France: EDP Sciences, 2006. http://dx.doi.org/10.1051/iufost:20060813.
Full textPigg, Joshua, Matthew Barley, Samier Ishtayeh, Jennifer C. Latimer, and Heather Foxx. "BIOAVAILABILITY OF LEAD IN URBAN SOILS." In GSA Annual Meeting in Denver, Colorado, USA - 2016. Geological Society of America, 2016. http://dx.doi.org/10.1130/abs/2016am-285193.
Full textGuido, Aida. "Bioavailability of Lead in Urban Soil Environments." In World Environmental and Water Resources Congress 2011. Reston, VA: American Society of Civil Engineers, 2011. http://dx.doi.org/10.1061/41173(414)327.
Full textJaisi, Deb, Hui Li, Mingjing Sun, and Spencer Moller. "Glyphosate degradation and bioavailability in soil system." In Goldschmidt2022. France: European Association of Geochemistry, 2022. http://dx.doi.org/10.46427/gold2022.12718.
Full textGollapalli, Lakshmi Sri Sai Kumar, Harish Vancha, Govindaiah Pilli, Sharfuddin Mohd, Sourabh Chatterjee, and Mahesh Hanmantrao Tidke. "Nanoemulsion: A novel strategy for bioavailability enhancement." In THE FOURTH SCIENTIFIC CONFERENCE FOR ELECTRICAL ENGINEERING TECHNIQUES RESEARCH (EETR2022). AIP Publishing, 2023. http://dx.doi.org/10.1063/5.0163704.
Full textWhitacre, Shane. "Predicting Arsenic Bioavailability in Moderately Contaminated Soils." In Proceedings of the 18th International Conference on Heavy Metals in the Environment. openjournals ugent, 2016. http://dx.doi.org/10.21825/ichmet.71351.
Full textAnnuzzi, Giovanni, Pasquale Arpaia, Umberto Cesaro, Ornella Cuomo, Mirco Frosolone, Sabrina Grassini, Nicola Moccaldi, and Isabella Sannino. "A customized bioimpedance meter for monitoring insulin bioavailability." In 2020 IEEE International Instrumentation and Measurement Technology Conference (I2MTC). IEEE, 2020. http://dx.doi.org/10.1109/i2mtc43012.2020.9128676.
Full textArchetti, Francesco, Stefano Lanzeni, Enza Messina, and Leonardo Vanneschi. "Genetic programming for human oral bioavailability of drugs." In the 8th annual conference. New York, New York, USA: ACM Press, 2006. http://dx.doi.org/10.1145/1143997.1144042.
Full textReports on the topic "Bioavailability"
Dorsey, John. Thermodynamically Correct Bioavailability Estimations. Fort Belvoir, VA: Defense Technical Information Center, October 1995. http://dx.doi.org/10.21236/ada305825.
Full textDorsey, John G. Thermodynamically Correct Bioavailability Estimations. Fort Belvoir, VA: Defense Technical Information Center, April 1992. http://dx.doi.org/10.21236/ada270889.
Full textGrossl, Paul R. Bioavailability of Allelochemicals in Soil. Fort Belvoir, VA: Defense Technical Information Center, February 2008. http://dx.doi.org/10.21236/ada495629.
Full textGadgoli, Chhaya, Archana Naik, Siddhi Bhandekar, and Harshala Bhere. Bioavailability and pharmacokinetic parameters of a formulation containing secoisolariciresinol diglucoside–rich extractdetermination of absolute bioavailability. Peeref, June 2023. http://dx.doi.org/10.54985/peeref.2306p3619596.
Full textDenit, Jeffery, and J. Gregory Planicka. Bioavailability: implications for science/cleanup policy. Office of Scientific and Technical Information (OSTI), December 1998. http://dx.doi.org/10.2172/799351.
Full textJobling, Michael, Mary H. Barcellos-Hoff, and Joni Mott. Bioavailability of TGF-Beta in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, August 2005. http://dx.doi.org/10.21236/ada444006.
Full textJobling, Michael F. Bioavailability of TGF-Beta in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, August 2004. http://dx.doi.org/10.21236/ada429598.
Full textIlla-Bochaca, Irineu, and Mary H. Barcellos-Hoff. Bioavailability of TGF-Beta in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, July 2007. http://dx.doi.org/10.21236/ada474704.
Full textBrown, B., and J. Neff. Bioavailability of sediment-bound contaminants to marine organisms. Office of Scientific and Technical Information (OSTI), September 1993. http://dx.doi.org/10.2172/10103045.
Full textPhipps, T. L., and L. A. Kszos. Bioavailability study for the Paducah Gaseous Diffusion Plant. Office of Scientific and Technical Information (OSTI), August 1996. http://dx.doi.org/10.2172/459741.
Full text